Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Jun. 30, 2015
Current assets:    
Cash $ 23,014 $ 9,494
Accounts receivable - trade 484 445
Accounts receivable - unbilled 122 0
Work in process 22 0
Prepaid expenses and other current assets 264 182
Total current assets 23,906 10,121
Fixed assets, net of accumulated depreciation 25,574 13
Intangible assets, net of accumulated amortization 2,092 2,360
Security deposit 28 0
Total Assets 51,600 12,494
Current liabilities:    
Accounts payable (related party of $200 and $153 as of June 30, 2016 and 2015, respectively) 1,177 1,104
Accrued expenses (related party of $623 and $0 as of June 30, 2016 and 2015, respectively) 920 159
Capital lease obligation - current portion 170 0
Deferred revenue 24 0
Total Current Liabilities 2,291 1,263
Capital lease obligation - net of current portion 25,265 0
Total Liabilities 27,556 1,263
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:    
Preferred stock - no par value; 1,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock - $0.001 par value; 175,000,000 shares authorized; 89,109,410 and 77,205,410 shares issued and outstanding as of June 30, 2016 and 2015, respectively 89 77
Additional paid-in capital 67,468 59,006
Accumulated other comprehensive loss (29) (25)
Accumulated deficit (57,591) (47,827)
Total iBio, Inc. Stockholders’ Equity 9,937 11,231
Noncontrolling interest 14,107 0
Total Equity 24,044 11,231
Total Liabilities and Equity $ 51,600 $ 12,494